INDOCO REMEDIES LTD. - 532612 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Enclosing herewith in Annexure A the details of the Show Cause Notice received from GST Authority INDOCO REMEDIES LTD. - 532612 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Enclosing herewith in Annexure A the details of the show cause notice (SCN) u/s 73(1) in Form GST DRC-01 received from the Goods and Service Tax (GST) Authority. INDOCO REMEDIES LTD. - 532612 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Notice for transfer of equity shares of the Company to IEPF INDOCO REMEDIES LTD. - 532612 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Advertisement confirming dispatch of the Postal Ballot Notice INDOCO REMEDIES LTD. - 532612 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Enclosed copy of the postal Ballot Notice dated 29-03-2024 (Postal Ballot Notice) to seek approval of the shareholders for special resolutions. INDOCO REMEDIES LTD. - 532612 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Enclosed the Annual Secretarial Compliance Report dated 16th May, 2024 for the Financial Year 2023-24 issued by our Secretarial Auditor CS Ajit Sathe ,Proprietor of M/s. A Y Sathe & Co., Company Secretaries. INDOCO REMEDIES LTD. - 532612 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Indoco Remedies receives final ANDA approval from USFDA for Pregabalin Capsules INDOCO REMEDIES LTD. - 532612 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Pursuant to the Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements), Regulations,2015, enclosed the transcript of Earnings Conference Call held on 16-05-2024 at 03.30 pm(IST). INDOCO REMEDIES LTD. - 532612 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Pursuant to Regulation 30 of SEBI LODR, we are enclosing herewith in Annexure A the details of the Show Cause Notice received from GST Authority INDOCO REMEDIES LTD. - 532612 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper publication of Audited Standalone and Consolidated Financial Results for the quarter and year ended 31st March, 2024